Wilkins Investment Counsel Inc
Source: SEC Form 13F · as of Mar 2026Wilkins Investment Counsel Inc holds 13 biotech & pharma companies tracked by BioSniper, totaling $100.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$100.6M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 246,748 | $29.7M |
| NVSNovartis AG | 112,677 | $17.2M |
| JNJJOHNSON & JOHNSON | 67,094 | $16.4M |
| IQVIQVIA Holdings Inc. | 81,969 | $14.0M |
| TECHBIO-TECHNE Corp | 174,115 | $9.1M |
| PFEPFIZER INC | 180,975 | $5.1M |
| ABBVAbbVie Inc. | 14,182 | $3.1M |
| ABTABBOTT LABORATORIES | 23,253 | $2.4M |
| LLYELI LILLY & Co | 2,484 | $2.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,510 | $409K |
| BMYBRISTOL MYERS SQUIBB CO | 6,700 | $406K |
| PMPhilip Morris International Inc | 2,082 | $344K |
| AMGNAMGEN INC | 751 | $264K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.